Viewpoint Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $829K | Buy |
10,000
+3,000
| +43% | +$249K | 0.41% | 54 |
|
|
2025
Q1 | $568K | Buy |
7,000
+5,000
| +250% | +$406K | 0.31% | 60 |
|
|
2024
Q4 | $180K | Buy |
+2,000
| New | +$180K | 0.09% | 103 |
|
|
2024
Q3 | – | Sell |
-3,000
| Closed | -$278K | – | 145 |
|
|
2024
Q2 | $278K | Buy |
3,000
+2,000
| +200% | +$185K | 0.17% | 87 |
|
|
2024
Q1 | $94.9K | Sell |
1,000
-1,000
| -50% | -$94.9K | 0.06% | 112 |
|
|
2023
Q4 | $179K | Buy |
2,000
+1,000
| +100% | +$89.3K | 0.12% | 98 |
|
|
2023
Q3 | $73K | Buy |
1,000
+200
| +25% | +$14.6K | 0.06% | 106 |
|
|
2023
Q2 | $66.6K | Hold |
800
| – | – | 0.05% | 104 |
|
|
2023
Q1 | $61K | Hold |
800
| – | – | 0.05% | 97 |
|
|
2022
Q4 | $66.4K | Hold |
800
| – | – | 0.06% | 94 |
|
|
2022
Q3 | $63K | Hold |
800
| – | – | 0.06% | 94 |
|
|
2022
Q2 | $59K | Hold |
800
| – | – | 0.06% | 99 |
|
|
2022
Q1 | $72K | Buy |
+800
| New | +$72K | 0.06% | 101 |
|